Stocks · NASDAQ · Healthcare · United States
NRIX — Nurix Therapeutics, Inc.
Nurix Therapeutics, Inc. (NRIX) is a healthcare stock listed on NASDAQ (United States). At the close of October 2, 2026 it traded at 22.99 (-1.50% on the day), -9.2% over one month, -5.8% over three months, +153.2% over twelve months. The InvestMuse composite score is +5 on a −100 to +100 scale, a mixed read that ranks #454 of about 1,229 assets. The strongest of its nine dimensions are Technical indicators (+34) and Momentum (+13); the weakest is Trend (-22). Its volatility regime from the hidden Markov model is Calm.
The facts
| Last close | 22.99 (October 2, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | -1.50% / -9.2% / -5.8% / +153.2% |
| 52-week range | 9.08 – 27.79 |
| Composite score | +5 / 100 · mixed view · rank #454 |
| Volatility regime (HMM) | Calm |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)0
- Technical indicators+34
- Trend-22
- Support / resistance0
- Fundamentals0
- Sector edge0
- News sentiment0
- Momentum+13
- Chart patterns and zones0
How this read is made
Every night InvestMuse scores about 1,229 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of October 2, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.